The U.S. Food and Drug Administration (FDA) announced plans to implement changes to its medical device clearance process that would rely far less on older predicate devices and offer a modernized pathway for high-tech medical innovations. The changes represent a significant shift in the way the FDA approves devices for marketing in the U.S., a process first introduced more than 40 years ago. Specifically, the agency plans to change the 510(k) pathway required for new medical devices to account for advances in medical technology. Read more here.
“SBIR/STTR Technology & Commercialization Forum”
- Jul 23 2019
Bunker Labs' "Muster Across America Tour"
- Aug 08 2019
TAEBC "Ask Me Anything" Session
- The Edney Innovation Center, 1100 Market Street, Chattanooga
- Aug 13 2019
Knoxville Technology Council Inaugural Event
- Jewelry TV, 9600 Parkside Drive, Knoxville
- Aug 15 2019
"36|86 Entrepreneurship Festival"
- Aug 28 2019